Table 2. Cox regression analysis to evaluate the predictive effect of SXscore and standard assessment on the outcomes with adjustment for confounding factors.
| Treatment | All-cause death | MACCE | |||
|---|---|---|---|---|---|
| HRadjusted† (95% CI) | P value | HRadjusted† (95% CI) | P value | ||
| MT alone | |||||
| SXscore≥23 | 7.93 (0.86–73.3) | 0.068 | 2.99 (0.20–45.80) | 0.431 | |
| LMMCAD | 4.13 (0.96–17.7) | 0.056 | 8.72 (1.73–44.10) | 0.009 | |
| PCI | |||||
| SXscore≥23 | 4.83 (0.41–57.00) | 0.211 | 3.16 (0.97–10.30) | 0.055 | |
| LMMCAD | 3.65 (0.67–19.9) | 0.134 | 1.28 (0.58–2.86) | 0.541 | |
| CABG | |||||
| SXscore≥23 | 0.75 (0.08–7.22) | 0.802 | 1.73 (0.46–6.51) | 0.416 | |
| LMMCAD | 0.66 (0.02–18.6) | 0.808 | 1.36 (0.33–5.56) | 0.670 | |
| Total sample | |||||
| SXscore≥23 | 1.83 (0.52–6.39)‡ | 0.344 | 1.42 (0.97–2.08)‡ | 0.069 | |
| LMMCAD | 2.81 (1.17–6.74)‡ | 0.021 | 1.71 (0.94–3.13)‡ | 0.081 | |
†, adjusted for age, male, BMI, diabetes mellitus, hypertension, previous myocardial infarction, HDL-C, creatinine, LVEF, current smoking, and chest pain. ‡, adjusted for therapeutic method, age, male, BMI, diabetes mellitus, hypertension, previous myocardial infarction, HDL-C, creatinine, LVEF, current smoking, and chest pain. MACCE, major adverse cardiac and cerebral events; MT, medical-therapy; SXscore, SYNTAX score; LMMCAD, left main or multivessel coronary artery disease; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting; BMI, body mass index; HDL-C, high-density lipoprotein cholesterol; LVEF, left ventricular fraction ejection.